SPOTLIGHT: Reactor shutdown impacts imaging at U.S. hospitals


Today, 20 million patients a year are injected with a radioactive isotope known as technetium-99, which helps in imaging used to diagnose a wide range of conditions. However, such treatments are being delayed by the temporary shutdown of a Canadian reactor which serves as North America's only source of technetium-99. The reactor may not open until mid-January. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.